News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,618 Results
Type
Article (2268)
Company Profile (6)
Press Release (71344)
Section
Business (22787)
Career Advice (11)
Deals (4743)
Drug Delivery (1)
Drug Development (8944)
Employer Resources (1)
FDA (1864)
Job Trends (896)
News (39266)
Policy (3675)
Tag
Academia (138)
Alliances (8496)
Alzheimer's disease (130)
Approvals (1868)
Artificial intelligence (7)
Bankruptcy (9)
Best Places to Work (673)
Biosimilars (10)
Biotechnology (8)
Breast cancer (10)
Cancer (117)
Cardiovascular disease (6)
Career advice (11)
Cell therapy (16)
Clinical research (7427)
Collaboration (42)
COVID-19 (194)
C-suite (7)
Data (113)
Diabetes (9)
Diagnostics (717)
Drug discovery (8)
Duchenne muscular dystrophy (7)
Earnings (7920)
Events (7751)
Executive appointments (25)
FDA (1931)
Funding (30)
Gene editing (7)
Gene therapy (11)
GLP-1 (40)
Government (249)
Healthcare (1220)
Infectious disease (198)
Inflammatory bowel disease (13)
IPO (1719)
Job creations (247)
Job search strategy (11)
Layoffs (7)
Legal (954)
Liver cancer (14)
Lung cancer (20)
Manufacturing (13)
MASH (8)
Medical device (1116)
Medtech (1117)
Mergers & acquisitions (3063)
Metabolic disorders (29)
Neuroscience (157)
NextGen Class of 2024 (264)
Non-profit (103)
Northern California (113)
Obesity (10)
Parkinson's disease (8)
Patents (10)
People (5315)
Phase I (2059)
Phase II (3163)
Phase III (2757)
Pipeline (50)
Postmarket research (254)
Preclinical (786)
Radiopharmaceuticals (23)
Rare diseases (18)
Real estate (613)
Regulatory (2608)
Reports (6)
Research institute (144)
Schizophrenia (6)
Series A (7)
Southern California (88)
Startups (448)
United States (876)
Vaccines (17)
Date
Today (15)
Last 7 days (77)
Last 30 days (341)
Last 365 days (3720)
2024 (3347)
2023 (4248)
2022 (7476)
2021 (6832)
2020 (6288)
2019 (4202)
2018 (3306)
2017 (3908)
2016 (3489)
2015 (4361)
2014 (3223)
2013 (2754)
2012 (2943)
2011 (3031)
2010 (2765)
Location
Africa (82)
Arizona (6)
Asia (21242)
Australia (2440)
California (228)
Canada (151)
China (79)
Connecticut (7)
Europe (13070)
Florida (9)
Illinois (14)
Japan (31)
Maryland (60)
Massachusetts (185)
Minnesota (21)
New Jersey (90)
New York (105)
North Carolina (55)
Northern California (113)
Pennsylvania (29)
South America (107)
Southern California (88)
Texas (12)
Utah (7)
Virginia (8)
Washington State (21)
73,618 Results for "zenith epigenetics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Zenith Epigenetics Proudly Supports Rare Disease Day
Zenith Epigenetics Ltd. (“Zenith” or the “Company”) announces its support of Rare Disease Day by highlighting our expanded development efforts of BET inhibitor ZEN-3694
February 29, 2024
·
5 min read
Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a global leader in epigenetics, announced today it has entered into an agreement with Cencora (formerly AmerisourceBergen) aimed at accelerating the commercialization of Zenith Epigenetics’ ZEN-3694 program.
October 26, 2023
·
7 min read
Zenith Epigenetics Reports Advancement of ZEN-3694 in NUT Carcinoma
Zenith Epigenetics Ltd. (“Zenith” or the “Company”) reports clinical activity and the advancement in development of its BET inhibitor (BETi) ZEN-3694 in patients with NUT carcinoma (NC). NC is a highly aggressive type of squamous cell cancer with very poor prognosis that often forms in the head, neck, or lungs.
June 1, 2023
·
6 min read
Press Releases
Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
September 24, 2024
·
3 min read
Pharm Country
West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy
West Pharmaceutical Services, Inc. announced that it will unveil its new Daikyo Crystal Zenith® Nested Vials in Tub at the International Society for Cell and Gene Therapy Annual Meeting taking place in Vancouver, Canada from May 29- June 1.
May 29, 2024
·
2 min read
Press Releases
Medline receives AARC’s 2024 Zenith Award for dedication to respiratory care
October 2, 2024
·
2 min read
Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials
Zenith Epigenetics Ltd. (“Zenith” or the “Company”) announced today that its leading BET inhibitor, ZEN-3694, is being evaluated in seven NCI sponsored clinical trials for safety and efficacy in multiple oncology indications with significant unmet need, through the NCI’s Cancer Therapy Evaluation Program (CTEP).
July 6, 2022
·
10 min read
Drug Development
Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
Zenith Epigenetics Ltd. (“Zenith” or the “Company”) announced today the initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) clinical trial combining ZEN-3694 + Pfizer Inc.’s Talzenna (talazoparib).
May 10, 2022
·
5 min read
BioMidwest
Epigenetic laboratory TruDiagnostic launches first ever organ-specific aging analysis from Yale-developed SYMPHONYAge algorithms
Marking a milestone development in epigenetic research and clinical health applications, laboratory TruDiagnostic is launching the first ever, epigenetic aging analysis of individual organ systems, using validated and system-specific trained clocks.
June 28, 2024
·
4 min read
Epigenetics Market Size Forested to be Worth over USD 61.04 Bn by 2033
According to the Vision Research Reports, the global epigenetics market size was estimated at around USD 14.65 billion in 2023 and it is forecasted to be worth over USD 61.04 billion by 2033 with a CAGR of 15.34% from 2024 to 2033
April 23, 2024
·
20 min read
1 of 7,362
Next
